NCT00783237View on ClinicalTrials.gov

Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)

PHASE4CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

December 1, 2003

Primary Completion Date

February 21, 2004

Study Completion Date

February 21, 2004

Conditions
Allergic Rhinitis
Interventions
DRUG

Mometasone

Mometasone Furoate Nasal Spray, single dose of 200 mcg (2 sprays per nostril)

DRUG

Placebo

Placebo nasal spray, single dose of 2 sprays per nostril

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00783237 - Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431) | Biotech Hunter | Biotech Hunter